Effects of treatment of myelodysplastic syndromes with recombinant human granulocyte colony stimulating factor.

P. Greenberg*, R. Negrin, A. Nagler, L. Souza, T. Donlon

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)151-161
Number of pages11
JournalProgress in Clinical and Biological Research
Volume338
StatePublished - 1990
Externally publishedYes

Funding

FundersFunder number
National Cancer InstituteR01CA036915

    Cite this